Showing results (91-100 of 114) with videos related to
Sort By:
Pageof 12
Biochemical and Biophysical Research Communications|January 14, 2010
Efficient cross-presentation of soluble exogenous antigens introduced into dendritic cells using a weak-based amphiphilic peptideNobuhito Ikeuchi, Junichiro Futami, Akihiro Hosoi, et al.Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry|June 11, 2013
High sensitive elemental analysis of single yeast cells (Saccharomyces cerevisiae) by time-resolved inductively-coupled plasma mass spectrometry using a high efficiency cell introduction systemAlexander S Groombridge, Shin-ichi Miyashita, Shin-ichiro Fujii, et al.Cancer Research|July 3, 2016
Systemic DC Activation Modulates the Tumor Microenvironment and Shapes the Long-Lived Tumor-Specific Memory Mediated by CD8+ T CellsKanako Shimizu, Satoru Yamasaki, Jun Shinga, et al.Frontiers in Immunology|July 12, 2019
Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFNKanako Shimizu, Satoru Yamasaki, Maki Sakurai, et al.British Journal of Cancer|October 30, 2024
Crucial immunological roles of the invasion front in innate and adaptive immunity in cervical cancerYuhya Hirahara, Kanako Shimizu, Satoru Yamasaki, et al.Blood|August 1, 2007
The developmental program of human dendritic cells is operated independently of conventional myeloid and lymphoid pathwaysFumihiko Ishikawa, Hiroaki Niiro, Tadafumi Iino, et al.Communications Biology|December 3, 2021
Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2Kanako Shimizu, Tomonori Iyoda, An Sanpei, et al.Journal of Clinical Immunology|April 27, 2012
Accumulation of activated invariant natural killer T cells in the tumor microenvironment after α-galactosylceramide-pulsed antigen presenting cellsKaoru Nagato, Shinichiro Motohashi, Fumihiro Ishibashi, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 10, 2006
A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancerShinichiro Motohashi, Aki Ishikawa, Eiichi Ishikawa, et al.The Journal of Experimental Medicine|March 17, 2004
In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccinationLaura C Bonifaz, David P Bonnyay, Anna Charalambous, et al.Pageof 12